Abiopharma

🔍 Lillie James Woodruff (Executive)

Company: MapLight Therapeutics, Inc. (MPLT)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 1,730 shares of Voting Common Stock at $26.82 per share (Direct)
  Date: 2026-04-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 297,940.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 686 shares of Voting Common Stock at $27.01 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 297,254.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,097 shares of Voting Common Stock at $27.49 per share (Direct)
  Date: 2026-04-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 295,157.00 | transaction_form_type: 4 | Footnotes: F1, F5

Footnotes:

• F1: Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units.
• F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.33 to $27.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5).
• F3: Includes 808 shares acquired under the Issuer's stock purchase plan on March 31, 2026.
• F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.2201 to $27.2197 inclusive.
• F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $27.9898 inclusive.